International Clinical Trial: A Study to Evaluate adding drug Fosaprepitant reduces incidence of Nausea and Vomiting after living Donor Liver Surgery

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116812) titled 'A Study to Evaluate adding drug Fosaprepitant reduces incidence of Nausea and Vomiting after living Donor Liver Surgery' on Sept. 1.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant, Investigator and Outcome Assessor Blinded

Primary Sponsor: Amrita Vishwa Vidyapeetham, Amrita Hospital, Faridabad

Condition: Health Condition 1: O- Medical and Surgical

Intervention: In...